Antimicrobial drug use and macrolide-resistant Streptococcus pyogenes, Belgium

31Citations
Citations of this article
47Readers
Mendeley users who have this article in their library.

Abstract

In Belgium, decreasing macrolide, lincosamide, streptogramins B, and tetracycline use during 1997-2007 correlated significantly with decreasing macrolide-resistant Streptococcus pyogenes during 1999-2009. Maintaining drug use below a critical threshold corresponded with low-level macrolide-resistant S. pyogenes and an increased number of erm(A)-harboring emm77 S. pyogenes with low fitness costs.

Cite

CITATION STYLE

APA

Van Heirstraeten, L., Coenen, S., Lammens, C., Hens, N., Goossens, H., & Malhotra-Kumar, S. (2012). Antimicrobial drug use and macrolide-resistant Streptococcus pyogenes, Belgium. Emerging Infectious Diseases, 18(9), 1515–1518. https://doi.org/10.3201/eid1809.120049

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free